Human CRACC/SLAMF7 Antibody, R&D Systems™

Mouse Monoclonal Antibody

Catalog Number	Mfr. No.	Quantity
MAB19061SP	R&D Systems MAB19061SP	25 μg
MAB19061100	R&D Systems MAB19061100	100 μg

Description

CRACC/SLAMF7 Monoclonal antibody specifically detects CRACC/SLAMF7 in Human samples. It is validated for Immunohistochemistry

Specifications

• Antigen: CRACC/SLAMF7
• Dilution: Immunohistochemistry 5-25 ug/mL
• Classification: Monoclonal
• Form: Purified
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
• Gene Alias: 19A, CD2 subset 1, CD2-like receptor activating cytotoxic cells, CD319, CD319 antigen, CRACCCD2-like receptor-activating cytotoxic cells, CS119A24 protein, Membrane protein FOAP-12, Novel Ly9, novel LY9 (lymphocyte antigen 9) like protein, Protein 19A, SLAM family member 7, SLAMF7
• Immunogen: Mouse myeloma cell line NS0-derived recombinant human CRACC/SLAMF7, Lys27-Ser225, Accession # Q9NQ25
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.

• Clone: 235622
• Applications: Immunohistochemistry
• Conjugate: Unconjugated
• Host Species: Mouse
• Target Species: Human
• Gene Accession No.: Q9NQ25
• Gene ID (Entrez): 57823
• Isotype: IgG2b
• Purification Method: Protein A or G purified from hybridoma culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 6 months, -20°C to -70°C under sterile conditions after reconstitution.